UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 196

Sortiert nach

Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: Machine learning on proteomics from the DETECT cohort

The European respiratory journal, 2021-06, Vol.57 (6), p.2002591

2021

Volltextzugriff (PDF)

Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial

The Journal of pediatrics, 2016-10, Vol.177, p.90-96.e3

2016

Volltextzugriff (PDF)

Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women

Journal of acquired immune deficiency syndromes (1999), 2008-06, Vol.48 (2), p.203

2008

Volltextzugriff (PDF)

Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion

AIDS (London), 2002-07, Vol.16 (11), p.1529-1535

2002

Volltextzugriff (PDF)

Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15

Journal of neurology, neurosurgery and psychiatry, 2015-11, Vol.86 (11), p.1202-1207

2015

Volltextzugriff (PDF)

MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis

ERJ open research, 2017-01, Vol.3 (1), p.74

2017

Volltextzugriff (PDF)

Barriers to use of free antiretroviral therapy in injection drug users

JAMA : the journal of the American Medical Association, 1998-08, Vol.280 (6), p.547

1998

Volltextzugriff (PDF)

LSO-092 Safety, efficacy and pharmacodynamics of cenerimod in patients with systemic lupus erythematosus: two randomised, double-blind phase 2 clinical trials

Lupus science & medicine, 2023-07, Vol.10 (Suppl 1), p.A93-A93

2023

Volltextzugriff (PDF)

Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation study

Molecular genetics and metabolism reports, 2022-06, Vol.31, p.100862-100862, Article 100862

2022

Volltextzugriff (PDF)

LO-016 The multifaceted immunomodulatory properties of cenerimod, a selective S1P1 receptor modulator, target three key aspects of SLE pathogenesis

Lupus science & medicine, 2023-07, Vol.10 (Suppl 1), p.A13-A14

2023

Volltextzugriff (PDF)

Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection

Canadian Medical Association journal, 2001-10, Vol.165 (7), p.889

2001

Volltextzugriff (PDF)

Education in Developing Countries: Rotterdam, 18-20 November 1963

1, 1963

Volltextzugriff (PDF)

Échange et développement

Revue d'économie du développement, 2013, Vol.21 (4), p.5-24

2013

Volltextzugriff (PDF)

Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study

BMC neurology, 2010-04, Vol.10 (1), p.28-28, Article 28

2010

Volltextzugriff (PDF)

The social determinants of emergency department and hospital use by injection drug users in Canada

Journal of urban health, 1999-12, Vol.76 (4), p.409-418

1999

Volltextzugriff (PDF)

Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada

Addiction (Abingdon, England), 1997-10, Vol.92 (10), p.1339-1347

1997

Volltextzugriff (PDF)

Impact of exposure to interferon beta-1a on outcomes in patients with relapsing–remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study

Therapeutic advances in neurological disorders, 2011-01, Vol.4 (1), p.3-14

2011

Volltextzugriff (PDF)

Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry

Annals of the rheumatic diseases, 2016-10, Vol.75 (10), p.1770-1776

2016

Volltextzugriff (PDF)

Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada

Addiction (Abingdon, England), 1997-10, Vol.92 (10), p.1339-1347

1997

Volltextzugriff (PDF)

Exchange and Development

1, 2010

Volltextzugriff (PDF)

Exchange and Development: An Anatomy of Economic Transactions

2010

Volltextzugriff (PDF)

Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort

Annals of the rheumatic diseases, 2016-09, Vol.75 (9), p.1736-1740

2016

Volltextzugriff (PDF)

First use of cenerimod, a selective S1P 1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study

Lupus science & medicine, 2019-10, Vol.6 (1), p.e000354

2019

Volltextzugriff (PDF)

HIV infection and risk behaviours among young gay and bisexual men in Vancouver

Canadian Medical Association journal, 2000-01, Vol.162 (1), p.21

2000

Volltextzugriff (PDF)

Rationale and design of the MODIFY study: A phase 3 multicenter, double-blind, randomized, placebo-controlled, parallel-group study to determine the efficacy and safety of lucerastat oral monotherapy in adult subjects with Fabry disease

Molecular genetics and metabolism, 2020-02, Vol.129 (2), p.S159-S159

2020

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: Machine learning on proteomics from the DETECT cohort

Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial

Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women

Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion

Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15

MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis

Barriers to use of free antiretroviral therapy in injection drug users

LSO-092 Safety, efficacy and pharmacodynamics of cenerimod in patients with systemic lupus erythematosus: two randomised, double-blind phase 2 clinical trials

Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation study

LO-016 The multifaceted immunomodulatory properties of cenerimod, a selective S1P1 receptor modulator, target three key aspects of SLE pathogenesis

Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection

Education in Developing Countries: Rotterdam, 18-20 November 1963

Échange et développement

Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study

The social determinants of emergency department and hospital use by injection drug users in Canada

Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada

Impact of exposure to interferon beta-1a on outcomes in patients with relapsing–remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study

Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry

Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada

Exchange and Development

Exchange and Development: An Anatomy of Economic Transactions

Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort

First use of cenerimod, a selective S1P 1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study

HIV infection and risk behaviours among young gay and bisexual men in Vancouver

Rationale and design of the MODIFY study: A phase 3 multicenter, double-blind, randomized, placebo-controlled, parallel-group study to determine the efficacy and safety of lucerastat oral monotherapy in adult subjects with Fabry disease

Suchergebnisse filtern